Erratum: Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity.

[This corrects the article DOI: 10.4103/ijo.IJO_708_18].

In the article titled “Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity” published in pages 884-8, issue 6, vol. 67 of Indian Journal of Ophthalmology,[1] the article title incorrectly published as “Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity” instead of “Intravitreal Aflibercept in Retinopathy of Prematurity: Report no: 1.”

Also under the “Methods” heading in the body text sentence is incorrectly published as “The clinical data of 46 consecutive Indian eyes referred to a tertiary eye care centre in South India, which received 0.025 ml (1 mg) of Aflibercept for High risk Prethreshold ROP, Threshold ROP, Aggressive-Posterior ROP (AP-ROP) was retrospectively analyzed.” Instead of “The Clinical data of 46 consecutive Indian eyes referred to Radhatri Nethralaya, a tertiary eye care centre in South India, which received 0.025 ml (1 mg) of Aflibercept for High risk Prethreshold ROP, Threshold ROP, Aggressive-Posterior ROP (AP-ROP) was retrospectively analyzed.”

The “How to cite this article” section should read correctly as “Vedantham V. Intravitreal Aflibercept in Retinopathy of Prematurity: Report no: 1. Indian J Ophthalmol 2019;67:884-8.”